Indonesia banned ingredients linked to the deaths of 70 children in Gambia from cough syrups as the Southeast Asian country investigates acute kidney damage that has killed more than 20 children in the capital Jakarta this year.
Food and drug regulator BPOM also said it was investigating the possibility that the ingredients, diethylene glycol and ethylene glycol, had contaminated other materials used as solvents.
Gambia and India are investigating the deaths from acute kidney injury in the west-African country thought to be linked to cough syrups made by New Delhi-based Maiden Pharmaceuticals Ltd.
The World Health Organization has said it found "unacceptable" levels of the ingredients, which can be toxic, in four Maiden products.
"To protect the public, BPOM has set a requirement at the time of registration that all medicinal syrup products for children and adults are not allowed to use diethylene glycol (DEG) and ethylene glycol (EG)," the regulator said in a statement.
The BPOM reiterated that the four products linked to the deaths in Gambia are not registered in Indonesia, nor are any other Maiden products.
Nine days after disaster, two pulled alive from Nepal hydropower tunnel
Germany launches manhunt after spate of sabotage attacks on power grid
Air India sack Phuket-Delhi pilot who failed drug test
Wildfires spread near Indonesia's new capital, prompting calls for action
Philippine court issues warrant for VP Duterte's arrest in grave threats case
Typhoon Saudel brings torrential rain, flooding to China's coastal areas
US investigates deadly strike on Iranian wedding
India food safety crackdown targets company of Nepal's 'Noodle King'
